Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gas Challenge
NCT04265053Phase 1Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Apr 2021
- Primary completion
- Mar 2025
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of indomethacin (2 arms), sponsored by University of Wisconsin–Madison. Primary endpoints: Cerebrovascular Conductance in Response to Hypoxia at 75 minutes and Cerebrovascular Conductance in Response to Hypercapnia at 75 minutes. Started Apr 2021; status: completed.
02
Drugs
indomethacin
Beyond the preview
Go deeper on NCT04265053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04265053.